期刊文献+

布鲁氏菌Omp2a-BtpB多表位疫苗结构预测及免疫模拟 被引量:1

Structure prediction and immune simulation of Brucella Omp2a-BtpB multi-epitope vaccine
下载PDF
导出
摘要 目的运用生物信息学方法对布鲁氏菌Omp2a和BtpB的T、B细胞优势表位进行预测、分析,从而构建多表位疫苗。方法从UniProt数据库中获取Omp2a和BtpB的氨基酸序列,应用I-TASSER构建三级结构。选取优势表位辅以佐剂构建多表位疫苗并进行免疫模拟。结果在Omp2a中获得2个B细胞优势表位,5个CTL细胞优势表位,3个Th细胞优势表位;在BtpB中获得1个B细胞优势表位,5个CTL细胞优势表位,1个Th细胞优势表位。构建的多表位疫苗为亲水性的稳定蛋白。结论基于生物信息学方法设计了新型布鲁氏菌多表位疫苗,为进一步研究相关疫苗提供理论基础。 Objective To predict and analyze T and B cell dominant epitopes of Omp2a and BtpB of Brucella by bioinformatics and construct a novel multi-epitope vaccine.Methods The amino acid sequences of the proteins,which were obtained from UniProt Database.Furthermore,the 3D structure of the proteins was builded by I-TASSER.Then being selected dominant epitopes and adjuvants to construct an multi-epitope vaccine and perform immune simulation.Results Two B cell dominant epitopes,five CTL cell dominant epitopes and three Th cell dominant epitopes were obtained in Omp2a.One B cell dominant epitope,five CTL cell dominant epitopes and one Th cell dominant epitope were obtained in BtpB.The constructed multi-epitope vaccine was a hydrophilic stable protein.Conclusion A novel Brucella multi-epitope vaccine is designed by using a bioinformatics approach,providing a theoretical basis for further research on Brucella vaccines.
作者 李敏 朱玥洁 胡金伟 顾挺 于明凯 陈志强 丁剑冰 张峰波 LI Min;ZHU Yuejie;HU Jinwei;GU Ting;YU Mingkai;CHEN Zhiqiang;DING Jianbing;ZHANG Fengbo(Medical Laboratory Center,the First Affiliated Hospital of Xinjiang Medical University,Xinjiang Uygur Autonomous Region,Urumqi 830054,China;Reproductive Pregnancy Center,the First Affiliated Hospital of Xinjiang Medical University,Xinjiang Uygur Autonomous Region,Urumqi 830054,China;Department of Immunology,Basic Medical College,Xinjiang Medical University,Xinjiang Uygur Autonomous Region,Urumqi 830011,China)
出处 《中国医药导报》 CAS 2022年第20期5-10,共6页 China Medical Herald
基金 国家自然科学基金地区科学基金项目(81860352)。
关键词 布鲁氏菌 表位 疫苗 Omp2a BtpB Brucella Epitope Vaccine Omp2a BtpB
  • 相关文献

参考文献3

二级参考文献29

  • 1Franco MP, Mulder M, Gilman RH,et al. [J].Lancet Infect Dis,2007,7(12) :75-786.
  • 2Arimi SM, Koroti E, Kang' ethe EK, et al. Risk of infection with Brucella abortus and Escherichia coli O157: HTassociated with marketing of unpasteurized milk in Kenya[J].Acta Trop, 2005,96(1) :1-8.
  • 3Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens [J]. Infect Genet Evol, 2009,9(6) : 1 168-1184.
  • 4Forland F, De Carvalho Gomes H, Nokleby H, et al. Applica- bility of evidence-based practice in public health: risk assess- ment on Q fever under an ongoing outbreak[J]. Euro Surveill, 2012,17(3) : 20060.
  • 5Dean AS, Bonfoh B, Kulo AE, et al. Epidemiology of brucel- losis and q Fever in linked human and animal populations in nortbern togo[J]. PLoS One,2013,8(8) : e71501.
  • 6Purwar S, Metgud SC, Gokale SK. Exceptionally high titres in atypical presentation of occult epididymo-orchitis due to bru- cellosis[J].J Med Microbiol,2012,61(Pt 3): 443- 445.
  • 7Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis:results of a multicentric study[J].Clin Microbiol Infect, 2014, 20(11) : 847-853.
  • 8Hasanoglu I, Guven T, Maras Y, et al. Brucellosis as an aeti: ology of septic arthritis[J].Trop Doer, 2014,44 ( 1 ) : 48-49.
  • 9Baldi PC, Giambartolomei GH. Pathogenesis and pathobiology of zoonotic brucellosis in humans[J]. Rev Off Int Epizoot, 2013,32(1) : 117-125.
  • 10Herrick JA, Lederman RJ, Sullivan B, et al. Brucella arteri- tis: clinical manifestalions, treatment, and prognosis [J ]. Lancet Infect Dis,2014,14(6) : 520-526.

共引文献38

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部